Promoter hypermethylation of FBXO32, a novel TGF-β/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer

✍ Scribed by Chou, Jian-Liang; Su, Her-Young; Chen, Lin-Yu; Liao, Yu-Ping; Hartman-Frey, Corinna; Lai, Yi-Hui; Yang, Hui-Wen; Deatherage, Daniel E; Kuo, Chieh-Ti; Huang, Yi-Wen

• Book ID: 109885324
• Publisher: Nature Publishing Group
• Year: 2010
• Tongue: English
• Weight: 558 KB
• Volume: 90
• Category: Article
• ISSN: 0023-6837
• DOI: 10.1038/labinvest.2009.138